Ledertrexate


Combined with:

Humira

Indications and Reactions:

Role Indications Reactions
Secondary
Rheumatoid Arthritis 29.5%
Drug Use For Unknown Indication 19.4%
Crohn's Disease 12.4%
Non-hodgkin's Lymphoma 12.4%
Acute Lymphocytic Leukaemia 10.9%
Hypertension 3.1%
Polyarthritis 3.1%
Product Used For Unknown Indication 1.6%
Anxiety 0.8%
Depression 0.8%
Gout 0.8%
Hypercholesterolaemia 0.8%
Hyperlipidaemia 0.8%
Insomnia 0.8%
Oesophagitis 0.8%
Osteoporosis 0.8%
Psoriatic Arthropathy 0.8%
Thrombosis Prophylaxis 0.8%
Herpes Zoster 14.8%
Lymphadenopathy 14.8%
Cytolytic Hepatitis 7.4%
Encephalopathy 7.4%
Hepatic Cirrhosis 7.4%
Interstitial Lung Disease 7.4%
Rectal Neoplasm 7.4%
Thymus Disorder 7.4%
Alanine Aminotransferase Increased 3.7%
Cholestasis 3.7%
Malignant Melanoma 3.7%
Pneumonia 3.7%
Pulmonary Fibrosis 3.7%
Sepsis 3.7%
Thrombocytopenia 3.7%
Concomitant
Drug Use For Unknown Indication 31.5%
Rheumatoid Arthritis 30.7%
Product Used For Unknown Indication 14.1%
Psoriatic Arthropathy 4.5%
Arthritis 3.4%
Polyarthritis 2.9%
Crohn's Disease 2.3%
Pain 2.0%
Osteoporosis 1.5%
Hypertension 1.2%
Arthralgia 1.0%
Stress 0.9%
Ankylosing Spondylitis 0.8%
Hypothyroidism 0.5%
Psoriasis 0.5%
Depression 0.4%
Procedural Pain 0.4%
Proctalgia 0.4%
Seborrhoea 0.4%
Hypersensitivity 0.4%
Weight Decreased 23.4%
Intervertebral Disc Protrusion 9.3%
Polyneuropathy 8.4%
Tuberculosis 7.5%
Anal Abscess 5.6%
Rheumatoid Arthritis 4.7%
Skin Ulcer 3.7%
Thrombocytopenia 3.7%
Atrial Fibrillation 2.8%
Breast Cancer 2.8%
Lymphadenopathy 2.8%
Myopathy 2.8%
Neuropathic Arthropathy 2.8%
Oropharyngeal Pain 2.8%
Osteoporosis 2.8%
Pneumonia 2.8%
Rectal Haemorrhage 2.8%
Salmonellosis 2.8%
Synovitis 2.8%
T-cell Lymphoma 2.8%

Drug Data